Published
SABCS program director Kate Lathrop, MD, talks with Komal Jhaveri, MD, FACP, about the results of phase 3 EMBER-3 trial, which evaluated the role of imlunestrant as monotherapy or in combination with abemaciclib in patients with ER+, HER2- advanced breast cancer whose disease had recurred or progressed during or after an aromatase inhibitor alone or with a CDK4/6 inhibitor.
- Categoria
- Oncology
Commenta per primo questo video.
Prossimo
-
11:39
The main results of the phase 3 Reverse-it trial
-
04:08
SABCS Snippets: Obesity and Breast Cancer Risk
-
05:07
SABCS Snippets: Results from the Breast Cancer Weight Loss (BWEL) Trial
-
07:16
SABCS Snippets: Results from the AFT-38 PATINA Trial
-
04:40
SABCS Snippets: Lobular Breast Cancer
-
06:00
SABCS Snippets: Risk-Reducing Surgeries and Survival in Young BRCA Carriers
-
04:05
SABCS Snippets: Breast Cancer in Younger Patients
-
06:04
SABCS Snippets: McGuire Memorial Lecture Award Recipient Laura J. van 't Veer, PhD
-
17:35
SABCS 2024 Highlights - EUROPA, TAILORx, PADMA, EMBER-3 with Dr. Jame Abraham
-
07:50
Atezolizumab Stumbles in Triple Negative Breast Cancer Study: SABCS 2024 Results with Charles Geyer
-
09:07
Cardiology for Beginners: Basics of Heart Sounds and Murmurs (with examples)
-
13:45
How to Become a Cardiologist | Cardiac Electrophysiologist
-
04:14
V 00592 Cardiology Fellowship Video Dr Vranian V5
-
05:17
Cardiology Fellowship at SIU Medicine
-
04:15
Cardiology Fellowship Program at Danbury Hospital
-
05:49
Practice Question: Cardiology #1, USMLE Step 1, COMLEX Level 1
-
04:07
Dr. Muhammed Raza on advice for Fellows interested in Interventional Cardiology
-
07:36
Congenital Heart Disease – Cardiology | Lecturio
-
05:18
Cardiology Fellowship at IU School of Medicine
-
04:36
What are different types of Cardiology Tests | SPS Hospitals
